The global cervical spacer systems market is experiencing strong growth and is projected to more than double over the next decade. Valued at USD 437.3 million in 2025, the market is anticipated to ...

More patients in the linerixibat group had clinically meaningful itch improvement (WI-NRS =3-point reduction) with 56% versus 43% in the placebo group at week 24 (treatment difference 13% [95% CI ...